San Francisco, CA, May 21, 2018 – Today, ProSomnus Sleep Technologies announced the addition of Edward T. Sall, MD, DDS, MBA as Medical Director for ProSomnus. As Medical Director, Dr. Sall will focus on enhancing physician acceptance of Oral Appliance Therapy for patients with Obstructive Sleep Apnea.
“As a Board-Certified Sleep Physician, Otolaryngologist, and Dentist trained in Sleep Medicine, I am in a unique position to drive the acceptance of OAT as the most effective treatment for the majority of patients with OSA,” stated Dr. Edward T. Sall, Medical Director for ProSomnus Sleep Technologies. “I am excited to be involved with a company that embraces the best technology, constant innovation with excellent vision, and leadership. My goal as Medical Director is to increase the acceptance of OAT for ProSomnus, their dentists and patients.”
According to the American Academy of Dental Sleep Medicine Guideline, Oral Appliance Therapy is recommended for patients who are intolerant of CPAP or prefer alternative therapy. Despite this guideline, each year hundreds of thousands of people with OSA go undiagnosed or remain untreated after they abandon CPAP. Studies report excellent patient compliance and satisfaction with ProSomnus Oral Appliance Therapy, and effective mean disease alleviation.
“ProSomnus Oral Appliance Therapy devices provide comfortable, efficacious, and affordable therapy for the millions of adults with Obstructive Sleep Apnea who prefer an alternative to CPAP,” stated Len Liptak, CEO of ProSomnus Sleep Technologies. “We are honored to add Dr. Sall to our team and are eager to work with him on the educational, scientific and awareness initiatives that will enhance access to better therapy for more people.”
“Dr. Sall brings a comprehensive perspective to help support research with our customers and partners in perfect alignment with ProSomnus’ commitment to evidence-based expansion of Oral Appliance Therapy. I am thrilled to have him on board,” stated David Kuhns, Vice President of Technology for ProSomnus Sleep Technologies.
Dr. Ed Sall obtained a DDS from Columbia University School of Dental and Oral Surgery. He attended SUNY Upstate Medical Center and received a MD, followed by a 5-year residency in Otolaryngology/Head and Neck Surgery. Dr. Sall became board certified in Sleep Medicine in 2012. Dr. Sall maintains an active medical and surgical practice in Sleep Disordered Breathing and has treated over 3,500 patients with Oral Appliance Therapy.
About ProSomnus Sleep Technologies
ProSomnus® Sleep Technologies designs, manufactures and markets FDA Cleared Class II Medical Devices dentists use to treat patients diagnosed with Obstructive Sleep Apnea. ProSomnus Devices are the first, precision oral appliance therapy devices designed to enhance compliance, mitigate side effects and, enable dentists to achieve excellent patient experiences and outcomes. They have been used to treat thousands of patients, with clinical performance that has been validated in randomize controlled trials, retrospective cohort studies, and numerous clinical case reports.
Media Contact
Heather Whalen, Associate VP, Marketing Communications
hwhalen@prosomnus.com